Tag: pharmaceutical patents

Federal Circuit Court: Authority on Pharmaceutical Patent Cases

The Federal Circuit Court holds exclusive authority over all U.S. pharmaceutical patent cases, shaping how generics enter the market, how patents are challenged, and how dosing innovations are protected. Its rulings on ANDA jurisdiction, Orange Book listings, and obviousness standards have transformed drug development and litigation.

Learn More